» Authors » Ivan Nemazanyy

Ivan Nemazanyy

Explore the profile of Ivan Nemazanyy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 1041
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Ramos-Brossier M, Romeo-Guitart D, Lante F, Boitez V, Mailliet F, Saha S, et al.
Cell Death Dis . 2024 Jan; 15(1):20. PMID: 38195526
In recent years, primary familial brain calcification (PFBC), a rare neurological disease characterized by a wide spectrum of cognitive disorders, has been associated to mutations in the sodium (Na)-Phosphate (Pi)...
12.
Julla J, Girard D, Diedisheim M, Saulnier P, Tran Vuong B, Bleriot C, et al.
Circ Res . 2023 Dec; 134(2):189-202. PMID: 38152893
Background: Diabetes is a major risk factor for atherosclerotic cardiovascular diseases with a 2-fold higher risk of cardiovascular events in people with diabetes compared with those without. Circulating monocytes are...
13.
Patitucci C, Hernandez-Camacho J, Vimont E, Yde S, Cokelaer T, Chaze T, et al.
Nat Commun . 2023 Dec; 14(1):8474. PMID: 38123539
Hepatic steatosis is the result of imbalanced nutrient delivery and metabolism in the liver and is the first hallmark of Metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD is the most...
14.
Tannoury M, Ayoub M, Dehgane L, Nemazanyy I, Dubois K, Izabelle C, et al.
Leukemia . 2023 Dec; 38(2):302-317. PMID: 38057495
Chronic lymphocytic leukemia (CLL) is still an incurable disease, with many patients developing resistance to conventional and targeted therapies. To better understand the physiology of CLL and facilitate the development...
15.
Cosialls E, Pacreau E, Duruel C, Ceccacci S, Elhage R, Desterke C, et al.
Cell Death Dis . 2023 Nov; 14(11):744. PMID: 37968262
Ferroptosis constitutes a promising therapeutic strategy against cancer by efficiently targeting the highly tumorigenic and treatment-resistant cancer stem cells (CSCs). We previously showed that the lysosomal iron-targeting drug Salinomycin (Sal)...
16.
Dos Santos L, Carbone F, Pacreau E, Diarra S, Luka M, Pigat N, et al.
Am J Pathol . 2023 Oct; 194(1):30-51. PMID: 37827216
Benign prostate hyperplasia (BPH) is caused by the nonmalignant enlargement of the transition zone of the prostate gland, leading to lower urinary tract symptoms. Although current medical treatments are unsatisfactory...
17.
Bayard C, Segna E, Taverne M, Fraissenon A, Hennocq Q, Periou B, et al.
J Exp Med . 2023 Sep; 220(11). PMID: 37712948
Hemifacial myohyperplasia (HFMH) is a rare cause of facial asymmetry exclusively involving facial muscles. The underlying cause and the mechanism of disease progression are unknown. Here, we identified a somatic...
18.
Bastin J, Sroussi M, Nemazanyy I, Laurent-Puig P, Mouillet-Richard S, Djouadi F
J Transl Med . 2023 Aug; 21(1):522. PMID: 37533102
Background: Colorectal cancer (CRC) can be classified into four molecular subtypes (CMS) among which CMS1 is associated with the best prognosis, while CMS4, the mesenchymal subtype, has the worst outcome....
19.
Ducroq S, Duplus E, Penalva-Mousset L, Trivelloni F, Lhonore A, Chabat-Courrede C, et al.
Environ Health Perspect . 2023 Jul; 131(7):77008. PMID: 37458746
Background: We have previously shown that chronic exposure of adult male mice to low doses of di(2-ethylhexyl) phthalate (DEHP) altered male sexual behavior and induced down-regulation of the androgen receptor...
20.
Alkhoury C, Henneman N, Petrenko V, Shibayama Y, Segaloni A, Gadault A, et al.
Nat Cell Biol . 2023 Jul; 25(7):975-988. PMID: 37414850
Metabolic demands fluctuate rhythmically and rely on coordination between the circadian clock and nutrient-sensing signalling pathways, yet mechanisms of their interaction remain not fully understood. Surprisingly, we find that class...